Reports from Colmaric Analyticals carry meaningful but not fully convergent public evidence.
Several solid signals support the laboratory's existence and operational history:
- The domain colmaricanalyticals.com has been registered since May 14, 2008.
- Collin Thomas is independently verified as President and CEO via his personal LinkedIn profile, which lists his tenure starting September 2008, corroborated by the company website.
- The laboratory discloses concrete instrumentation including HPLC-UV and LC-MS.
- It lists specific peptide analytes such as BPC-157, TB-500, semaglutide, and tirzepatide.
- Community sources describe Colmaric as an established third-party testing lab, and a forum user on Evolutionary.org reported calling the laboratory directly to confirm it conducts third-party testing and encourages customers to verify individual lots.
- The laboratory's Florida LLC registration (L21000153402, filed April 9, 2021) is checkable on Sunbiz.
The public evidence does not converge to the highest rating for one concrete reason: the laboratory advertises a certificate-verification page on its website, but that page returns HTTP 404 when fetched, meaning the single mechanism by which a customer could independently confirm a reported result is currently non-functional. This is the specific open concern that places the laboratory under Watch rather than at a higher tier.
Separately, the claimed ISO/IEC 17025:2017 accreditation could not be located in any accreditation body's register, and no business-register entry predating the 2021 Florida filing was found - but for a laboratory whose public ordering route addresses business customers, these absences are normal public-evidence limits, not faults. An address inconsistency exists between LinkedIn (St. Petersburg, Florida) and commercial directories (Goodlettsville, Tennessee), neither confirmed as the official registered office. These are signals, not a verdict.